Aromatherapy for dementia

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 2, 2014, Pages

  Forrester, Lene Thorgrimsen ^a   Maayan, Nicola ^b   Orrell, Martin ^c   Spector, Aimee E ^c   Buchan, Louise D ^d   Soares Weiser, Karla ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b Enhance Reviews Ltd   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NHS GRAMPIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL OIL; PLACEBO;

ADVERSE EVENT; AGITATION; AROMATHERAPY; BURN; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DATA ANALYSIS; DEMENTIA; DISEASE SEVERITY; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; BEHAVIOR; META ANALYSIS; RESTLESSNESS;

AROMATHERAPY; BEHAVIORAL SYMPTOMS; DEMENTIA; HUMANS; OILS, VOLATILE; PSYCHOMOTOR AGITATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907646344     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003150.pub2     Document Type: Review

References (95)

1. Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe an effective treatment for the management of agitation in severe dementia: the results of a double-blind placebo-controlled trial with Melissa. Journal of Clinical Psychiatry 2002;63(7):553-558.
2. Lee L, Reichelt K, Ballard C, Perry E. Melissa aromatherapy as safe and effective treatment. Nursing & Residential Care 2003;5(2):80-2.
3. Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJR, et al.A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2011;31:158-64.
4. Cameron H, du Toit S, Richard G, Bearns L. Using lemon balm oil to reduce aggression and agitation in dementia: results of a pilot study. Journal of Dementia Care 2011; Vol. 19, issue 5:36-8.
5. Fu CY, Moyle W, Cooke M. A randomised controlled trial of the use of aromatherapy and hand massage to reduce disruptive behaviour in people with dementia. BMC Complementary and Alternative Medicine 2013;13:165.
6. Lin PW-K, Chan W-C, Ng BF-L, Lam LC-W. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: A cross-over randomized trial. International Journal of Geriatric Psychiatry 2007;22(5):405-10.
7. O'Connor DW, Eppingstall B, Taffe J, van der Ploeg ES. A randomized, controlled cross-over trial of dermally-applied lavender (Lavandula angustifolia) oil as a treatment of agitated behaviour in dementia. BMC Complementary and Alternative Medicine 2013;13:315.
8. van der Ploeg ES, Eppingstall B, O'Connor DW. The study protocol of a blinded randomised-controlled cross-over trial of lavender oil as a treatment of behavioural symptoms in dementia. BMC Geriatrics 2010; Vol. 10:49.
9. Smallwood J, Brown R, Coulter F, Irvine E, Copland C. Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial. International Journal of Geriatric Psychiatry 2001;16:1010-3.
10. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry 2003;74:863-6.
11. Bowles EJ, Griffiths DM, Quirk L, Brownrigg A, Croot K. Effects of essential oils and touch on resistance to nursing care procedures and other dementia related behaviours in a residential care facility. International Journal of Aromatherapy 2002;12(1):22-9.
12. Brooker DJR, Snape M, Johnson E, Ward E, et al.Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia. British Journal of Clinical Psychology 1997;36:287-96.
13. Burleigh S, Armstron C. On the scent of useful therapy. Journal of Dementia Care 1997;July/August:21-23.
14. Chaiyana W, Okonogi S. Inhibition of cholinesterase by essential oil from food plant. Phytomedicine 2012;19:836-9.
15. Cohen-Mansfield J, Thein K, Marx MS, Dakheel-Ali M, Murad H, Freedman LS. The relationships of environment and personal characteristics to agitated behaviors in nursing home residents with dementia. Journal of Clinical Psychiatry 2012;73:392-9.
16. Cohen-Mansfield J, Marx MS, Freedman LS, Murad H, Thein K, Dakheel-Ali M. What affects pleasure in persons with advanced stage dementia?. Journal of Psychiatric Research 2012;46:402-6.
17. Cooper C, Mukadam N, Katona C, Lyketsos CG, Ames D, Rabins P, et al.Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. International Psychogeriatrics 2012;24:856-70.
18. Fung KM, Tsang HW, Chung RC. A systematic review of the use of aromatherapy in treatment of behavioral problems in dementia. Geriatrics & Gerontology International 2012;12:372-82.
19. Gray SG, Clair AA. Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioural challenges. American Journal of Alzheimer's Disease & Other Dementias 2002;17(3):169-74.
20. Guendling A, Guendling PW. Aroma therapy in dementia. European Journal of Integrative Medicine 2010;Conference: III European Congress for Integrative Medicine, ECIM 2010 Berlin Germany. Conference Start: 20101203 Conference End: 20101204. Conference Publication.
21. Henry J. Aroma groups improve the quality of life in Alzheimer's disease. The International Journal of Aromatherapy 1993;5(1):27-9.
22. Holmes C, Hopkins V, Hensford C, MacLaughlin V, Wilkinson D, Rosenvinge H. Lavender oil as a treatment for agitated behaviour in severe dementia. International Journal of Geriatric Psychiatry 2002;13 Suppl 2:277.
23. Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K. Effect of aromatherapy on patients with Alzheimer's disease. Psychogeriatrics 2009; Vol. 9, issue 4:173-9.
24. Kaufmann D, Dogra AK, Wink M. Myrtenal inhibits acetylcholinesterase, a known Alzheimer target. Journal of Pharmacy and Pharmacology 2011;63:1368-71.
25. Kilstoff K, Chenoweth L. New approaches to health and well-being for dementia day-care clients, family carers and day-care staff. International Journal of Nursing Practice 1998;4:70-83.
26. Kimura T, Takamatsu J. Pilot study of pharmacological treatment for frontotemporal lobar degeneration: Effect of lavender aroma therapy on behavioral and psychological symptoms. Geriatrics & Gerontology International 2013;13(2):516-7. [DOI: 10.1111/ggi.12025]
27. Klages K, Zecevic A, Orange JB, Hobson S. Potential of Snoezelen room multisensory stimulation to improve balance in individuals with dementia: a feasibility randomized controlled trial. Clinical Rehabilitation 2011; Vol. 25, issue 7:607-16.
28. Korn L, Logsdon R, Polissar N, Gomez-Beloz A, Waters T, Ryser R. A randomized trial of polarity therapy for stress and pain reduction in American Indian and Alaska Native family dementia caregivers. BMC Complementary and Alternative Medicine 2012;Conference: International Research Congress on Integrative Medicine and Health 2012 Portland, OR United States. Conference Start: 20120515 Conference End: 20120518. Conference Publication.
29. Hritcu L, Cioanca O, Hancianu M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 2012;19:529-34.
30. MacMahon S, Kermode S. A clinical trial of the effects of aromatherapy on motivational behaviour in a dementia care setting using a single subject design. The Australian Journal of Holistic Nursing 1998;52:47-9.
31. Mitchell S. Aromatherapy's effectiveness in disorders associated with dementia. The International Journal of Aromatherapy 1993;5(2):20-3.
32. Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. The International Journal of Neuroscience 2003;113(1):15-38.
33. Opie J, Rosewarne R, O'Connor DW. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Australian and New Zealand Journal of Psychiatry 1999;33(6):789-99.
34. Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR. Short-term study on the effects of rosemary on cognitive function in an elderly population. Journal of Medicinal Food 2012;15:10-7.
35. Sakamoto Y, Ebihara S, Ebihara T, Tomita N, Toba K, Freeman S, et al.Fall prevention using olfactory stimulation with lavender odor in elderly nursing home residents: a randomized controlled trial. Journal of the American Geriatrics Society 2012;60:1005-11.
36. Snow AL, Hovanec L, Brandt J. A controlled trial of aromatherapy for agitation in nursing home patients with dementia. Journal of Alternative and Complementary Medicine 2004;10(3):431-7.
37. Watanabe S, Iino H, Miyajima M, Hara K, Ohta K, Matsuda A, et al.The effect of ylang-ylang aroma on auditory p300 event-related potentials in temporal lobe epilepsy. Epilepsy Currents 2010;Conference: 64th Annual Meeting of the American Epilepsy Society, AES and III Biennial North American Regional Epilepsy Congress San Antonio, TX United States. Conference Start: 20101203 Conference End: 20101207. Conference Publication.
38. West BJM, Brockman SJ. The calming power of aromatherapy. Journal of Dementia Care 1994;March/April:20-22.
39. Wolfe, N, Herzberg J. Can aromatherapy oils promote sleep in severely demented patients?. International Journal of Geriatric Psychiatry 1996;11(10):926-7.
40. Woods DL, Craven R, Whitney J. The effects of therapeutic touch on disruptive behaviours of individuals with dementia of the Alzheimer's type. Alternative Therapies 1996;4(2):95-6.
41. Myers. Investigating cognitive effects of aromatherapy on people with dementia living in residential care facilities. ISRCTN Register 2005.
42. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
43. Arruda M, Viana H, Rainha N, Neng NR, Rosa JS, Nogueira JMF, do Carmo Barreto M, et al.Anti-acetylcholinesterase and antioxidant activity of essential oils from Hedychium gardnerianum Sheppard ex Ker-Gawl. Molecules 2012;17:3082-92.
44. Barnes J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. regulation and quality. Pharmacology Research and Perspectives 2003;55(3):226-33.
45. Blau T. Quality of life, social indicators, and criteria of change. Professional Psychology 1977;8:464-73.
46. Brooker DJR, Sturmey P, Gatherer AJH, Summerbelll C. The Behaviour Assessment Scale Of Later Life (BASOLL): A description, factor analysis, scale development, validity and reliability data for a new scale for older adults. International Journal of Geriatric Psychiatry 1993;8:747-54.
47. Buckle J. Clinical Aromatherapy, 2nd EditionESSENTIAL OILS IN PRACTICE. Clinical Aromatherapy, 2nd Edition. Essential oils in practice. Elsevier, 2003.
48. Chen YS, Chen FQ, Zhao JX, Tian YX. Progression of theory and application of acupuncture on treatment of vascular dementia. Chinese Journal of Clinical Rehabilitation 2004;8:4664-6.
49. Chioca LR, Antunes VD, Ferro MM, Losso EM, Andreatini R. Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice. Life Sciences 2013;30(92):20-1.
50. Cohen-Mansfield J, Marx MS, Rosentham AS. A description of agitation in a nursing home. Journal of Gerontology 1989;5:20-4.
51. Cohen-Mansfield J. Measurement of inappropriate behaviour associated with dementia. Journal of Gerontological Nursing 1999;25(2):42-51.
52. Cummings JL, Mega M, Gray K, et al.The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14.
53. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. Chichester, UK: www.cochrane-handbook.org, updated September 2009.
54. Degel J, Piper D, Koster EG. Implicit learning and implicit memory for odors: the influence of odor identification and retention time. Chemical Senses 2001;26:267-80.
55. Finkel SI, Lyons JS, Anderson RI. A brief agitation ratings scales (BARS) for nursing homes, elderly. Journal of the American Geriatric Society 1993;41:50-2.
56. Fleischman DA, Wilson RS, Gabrieli JD, Schneider JA, Bienias JL, Bennett DA. Implicit memory and Alzheimer's disease neuropathy. Brain 2005;128:2006-15.
57. Folstein NF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12:189-98.
58. Halycon. Aromatherapy Matrix of Essential Oils. http://www.halycon.com/kway/matix 2000.
59. Harris P, Rees R. The prevalence of complementary and alternative medicine use among the general population: a systematic review of the literature. Complementary Therapies in Medicine 2000;8:88-96.
60. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
61. Homes C, Ballard C. Aromatherapy in dementia. Advances In Psychiatric Treatment 2004;10:296-300.
62. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. British Journal of Psychiatry 1982;140:556-72.
63. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathologica 2010;120:287-96.
64. Kong E-H, Evans LK, Guevara JP. Nonpharmacological intervention for agitation in dementia: a systematic review and meta-analysis. Aging and Mental Health 2009;13(4):512-20.
65. Lin PW, Chan WC, Ng BF, Lam LC. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older person with dementia: a cross-over randomised trial. International Journal of Geriatric Psychiatry 2007;22(5):405-10.
66. Luiselli JL, Steinmann DL, Marholin ID, Steinmann WM. Evaluation of progressive muscle relaxation with conduct problem, learning disabled children. Child Behaviour Therapy 1982;3(2-3):41-5.
67. Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 2007 Apr 9;45(8):1823-31.
68. Machado S, Cunha M, Minc D, Portella CE, Velasques B, Basile LF, et al.Alzhemier's disease and implicit memory. Arquivos de Neuro-Psiquiatria [Brasilian Academy of Neurology] 2009;37(2A):334-42.
69. Mahoney F, Barthel D. Functional evaluation: the Barthel Index. Maryland State Medical Journal 1965;14:56-61.
70. McShane R, Nagy Z, Esiri M, King E, Joachim C, Sullivan N, Smith A. Anosmia in dementia is associated with lewy bodies rather than Alzheimer's pathology. Journal of Neurology, Neurosurgery, and Psychiatry 2001;70(6):739-43.
71. Moses G. Complementary and alternative medicine use in the elderly. Journal of Pharmacy Practice and Research 2005;16(7):419-22.
72. Nguyen QA, Paton C. The use of aromatherapy to treat behavioural problems in dementia. International Journal of Geriatric Psychiatry 2008 Apr;23(4):337-46.
73. Nolan L. Caring for people with dementia in the acute setting: a study of nurses's views. British Journal of Nursing 2007;16(7):419-22.
74. Ohmori A, Shinomiya K, Utsu Y, Tokunaga S, Hasegawa Y, Kamei C. Effect of santalol on the sleep-wake cycle in sleep-disturbed rats. Japanese Journal of Psychopharmacology 2007;27(4):167-71.
75. OnHealth Network Company. Alternative Practices. http://www.onhealth.com/alternatvie/resource/althealth 2000.
76. Perry E. Aromatherapy for the treatment of Alzheimer's disease. The Journal of Quality Research In Dementia Issues 2006, issue 3:http://alzheimers.org.uk/site/scripts/documents_info.php?documentID=306&pageNumber=2.
77. Perry E, Howes MJ. Medicinal plants and dementia therapy: herbal hopes for brain aging?. CNS Neuroscience & Therapeutics 2011 Dec;17(6):683-98.
78. Qiu C, De Ronchi D, Fragtiglioni L. The epidemiology of the dementias: an update. Current Opinions In Psychiatry 2007;20(4):380-5.
79. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
80. Rosen J, Burgio L, Kollar M, Cain M, Allison M, Fogleman M, et al.The Pittsburg Agitation Scale: a user friendly instrument for rating agitation in dementia. American Journal of Geriatric Psychiatry 1994;2:52-9.
81. SAS Institute Inc. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc., 1999.
82. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al.Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359-83.
83. Shaaban HAE, El-Ghorab AH, Shibamoto T. Bioactivity of essential oils and their volatile aroma components: review. Journal of Essential Oil Research 2010;24(2):203-12.
84. Shinde VM, Dhalwal K, Potdar M, Mahadik KR. Application of quality control principles to herbal drugs. International Journal of Phytomedicine 2009;1:4-8.
85. Suzuki M, Tatsumi A, Otsuka T, Kikuchi K, Mizuta A, Makino K, Kimoto A, et al.Massage on elderly patients with severe dementia. American Journal of Alzheimer's Disease & Other Dementias 2010;25(8):680-6.
86. Tariku Y, Hymete A, Hailu A, Rohloff J. Essential-oil composition, antileishmanial, and toxicity study of Artemisia abyssinica and satureja punctata ssp. Punctata from Ethiopia. Chemistry and Biodiversity 2010;7(4):1009-18.
87. Tisserand R. Aromatherapy for everyone. London: Penguin, 1988.
88. Tisserand R. Essential oil safety. The International Journal of Aromatherapy 1966;7(3):28-32.
89. Turek C, Stintzing FC. Stability of essential oils: a review. Comprehensive Reviews In Food Science and Food Safety 2013;12:40-53.
90. Vogel A, Stokholm J, Gade A, Andersen BB, Hejl BB, Waldemar G. Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight?. Dementia and Geriatric Cognitive Disorders 2004;17(3):181-7.
91. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology 2002;54(8):1616-25.
92. Walker MP, Ballard CG, Ayre GA, Wenes K, Cummings JL, McKeith IG, O'Brien JT. The clinician assessment of fluctuation and the one day fluctuation assessment scale. Two methods to assess fluctuating confusion in dementia. The British Journal of Psychiatry 2002;177:252-6.
93. World Health Organization. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. Geneva: World Health Organization, 1993.
94. Zald DH, Pardo JV. Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proceedings of the National Academy of Sciences of the United States of America 1997;94(8):4119-24.
95. Thorgrimsen LM, Spector AE, Wiles A, Orrell M. Aroma therapy for dementia. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003150]